跳至主要内容
临床试验/NCT01696721
NCT01696721招募中不适用

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

Massachusetts General Hospital51 个研究点 分布在 3 个国家目标入组 5,000 人开始时间: 2012年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
5,000
试验地点
51
主要终点
Establish Registry

研究概览

简要总结

In previous studies, Proton Beam Radiation Therapy (PBRT) has been found to show better results in treating patients with cancer, both because there is better control of where in the body the radiation is directed and because it is associated with less severe long term side effects. However, there is limited published data demonstrating these results. The goal of the Proton and Photon Consortium Registry (PPCR) is to enroll children treated with radiation in order to describe the population that currently receives radiation and better compare the short-term and long-term benefits of different types of radiotherapy. The data collected from this study will help facilitate research on radiation therapy and allow for collaborative research. The PPCR will collect demographic and clinical data that many centers that deliver radiation therapy already collect in routine operations.

详细描述

Once you are enrolled in the study, you will receive treatment, evaluations and follow up care for your type of cancer as determined by your treating physician according to clinical judgment and standard of care for your clinic. All treatments that you receive will be recorded, including all surgeries and chemotherapy given before or after PBRT. Treatment outcomes, like how you respond to treatment, side effects, and progression of your cancer will be collected as the information becomes available. A study coordinator or research nurse at your clinic will perform a chart review annually to update your status in the database. The study doctor will request any new data within the past year from you or your doctor.

We will be collecting the following data for the Registry:

At Screening: The following data will be collected from the time of diagnosis and initial staging:

  • Patient demographics, date of birth, gender, race, zip code and insurance status
  • Date of diagnosis
  • Histologic or clinical diagnosis and staging relevant to diagnosis
  • Imaging studies obtained and tumor measurements
  • Lab evaluations which include routine blood tests, hormone levels, and any relevant lab results needed to assess you and baseline and follow-up visits
  • Referring physician contact information

Treatment Data Collection: The following data regarding treatment will be collected:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Eligibility Criteria:
  • Patients treated with radiation therapy at one of the participating centers
  • Age < 22 at time of treatment start.
  • Patients may be enrolled regardless of previous local or systemic treatments received prior to enrollment in the PPCR.
  • Patients may be enrolled regardless of other current local or systemic treatments or disease extent.
  • Patients may be enrolled on the PPCR concurrently with another study or clinical trial.

排除标准

  • 未提供

研究组 & 干预措施

Pediatric Patients Treated with Protons

Proton Radiation Therapy

干预措施: No intervention (Other)

结局指标

主要结局

Establish Registry

时间窗: 2 years

Establish a registry of pediatric patients treated with proton radiation therapy in the United States

次要结局

  • Describe acute and late effects(2 years)
  • Describe patterns of care(2 years)
  • Establish a cohort of photon-treated patients(2 years)
  • Describe patterns of follow-up(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Torunn Yock, MD

Principal Investigator

Massachusetts General Hospital

研究点 (51)

Loading locations...

相似试验

进行中(未招募)
不适用
Phase II Study of Proton Radiation Therapy for NeuroblastomaGanglioneuroblastomaNeuroblastoma
NCT02112617Massachusetts General Hospital30
进行中(未招募)
不适用
Ultrahypofractionation and Normal Tissue ToxicityBreast Cancer FemaleBreast Cancer Stage IIBreast Cancer Stage IIIMyocardial FibrosisBreast Cancer
NCT05912231Massachusetts General Hospital60
已完成
不适用
Proton Radiation Therapy (RT) for the Treatment of Pediatric RhabdomyosarcomaRhabdomyosarcoma
NCT00592592Massachusetts General Hospital115
进行中(未招募)
3 期
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal CancerClinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8Thoracic Esophagus Squamous Cell Carcinoma
NCT03801876NRG Oncology300
进行中(未招募)
2 期
Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck CancerHead and Neck Cancer
NCT02923570Memorial Sloan Kettering Cancer Center108